Outcome
    Moderate Evidence

    Omega-3 Fatty Acids for Menstrual Cramp Relief

    Omega-3 supplementation reduced menstrual pain intensity and ibuprofen use in RCTs, with effects growing across 2–3 cycles.

    Overview

    Omega-3 supplementation reduced menstrual pain intensity and ibuprofen use in RCTs, with effects growing across 2–3 cycles.

    How It Works

    EPA/DHA shift eicosanoid synthesis toward less inflammatory series-3 prostaglandins, directly countering the prostaglandin excess that drives uterine cramping.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1–2 g/day combined EPA+DHA, continuous with meals.
    Expected timeframe
    Three menstrual cycles

    Protocol

    form
    Fish oil or algal oil. Check the EPA+DHA content rather than the capsule weight - a 1,000 mg capsule often supplies only 300 mg
    duration
    Three full menstrual cycles before judging
    co factor
    Take daily and continuously, not just during the period - the mechanism depends on membrane incorporation, which takes weeks. Some trials combined omega-3 with vitamin E. Evidence is moderate and reasonably consistent. Meta-analyses of randomised trials in primary dysmenorrhoea report that omega-3 supplementation reduces pain intensity and analgesic use compared with placebo, with effects appearing after two to three cycles. The mechanism is coherent: menstrual cramping is driven by prostaglandin F2-alpha and E2 produced from arachidonic acid in the endometrium, causing uterine contraction and ischaemia, and EPA and DHA displace arachidonic acid from membrane phospholipids, shifting production towards less potent series-3 prostaglandins. This is the same pathway NSAIDs block, more slowly and less completely.
    titration
    Up to 2,000 mg/day EPA+DHA; dysmenorrhoea trials used roughly 1,000-2,500 mg/day
    starting dose
    1,000 mg/day combined EPA+DHA with a fat-containing meal

    Evidence

    What the studies say

    RCTs in young women with primary dysmenorrhea show 1–2 g/day EPA+DHA significantly reduced pain scores and NSAID consumption vs placebo; one trial found fish oil comparable to ibuprofen for pain control.

    The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials

    Score: 8/10
    2022
    meta_analysis

    Mohammadi MM, Mirjalili R, Faraji A

    The results of the meta-analysis showed that n-3 PUFAs reduce the severity of primary dysmenorrhea in women (SMD = -1.075, 95% CI: -1.871 to -0.279)

    View source

    Safety

    Caveats

    Fishy aftertaste minimized with enteric coating or frozen capsules; mild antiplatelet effect at high doses.

    Less likely to help if

    Secondary dysmenorrhea (endometriosis, adenomyosis) responds poorly — screen first.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.